Rebecca Taub, President, R&D, and CMO at MADRIGAL PHARMACEUTICALS, INC. (MDGL), sold 3,378 shares at $273.41 ($924K) on 2025-01-17, disclosed to the SEC on 2025-01-17.
Open-market sale of $924k MDGL by President, R&D, and CMO. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $273.41 | 1,689 | $462K | 50.0% |
| 2 | $273.41 | 1,689 | $462K | 50.0% |
| Total | $273.41 avg | 3,378 | $924K | 100% |
| Filing → |
| MDGL | SELL | 2026-01-20 | $1.1M | — | Filing → |
| MDGL | SELL | 2026-01-13 | $18.9M | — | Filing → |
| MDGL | SELL | 2026-01-13 | $242K | — | Filing → |